Drug maker Biogen Idec Inc needs to wait more on bringing its multiple sclerosis drug in the market as the U.S. Food and Drug Administration has extended the review process by three months. Biogen was expecting to launch the drug, Plegridy, by mid-2014. Plegridy is an injectable drug designed to reduce the dosing schedule of standard interferon drugs such as Biogen's own Avonex. According to … [Read more...]
You are here: Home / Archives for FDA Plegridy